Clinical Trials Browser

Phase 1 × Terminated × Plasmacytoma × Clear all

NCT03031730 2026-02-10

Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma

Phase 1 Terminated

35 enrolled 10 charts

Multiple Myeloma, Plasmacytoma

NCT05350163 2024-12-10

T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

Phase 1 Terminated

11 enrolled 11 charts

LymphoidOther hematologic neoplasmPlasma cell

Plasmacytoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma